Antimicrobial Susceptibility of Pseudomonas aeruginosa to Ceftazidime-Avibactam, Ceftolozane-Tazobactam, Piperacillin-Tazobactam, and Meropenem Stratified by U.S. Census Divisions: Results from the 2017 INFORM Program
Published in
Antimicrobial Agents and Chemotherapy, November 2018
P. aeruginosa isolates (n = 1,909) were collected from 70 United Sates medical centers and susceptibility tested by broth microdilution method. Ceftazidime-avibactam (MIC50/90, 2/8 mg/liter) and ceftolozane-tazobactam (MIC50/90, 0.5/2 mg/liter) were the most active (highest susceptibility rates) compounds after colistin, with national susceptibility rates of 96.9% and 97.5%, respectively. Overall, piperacillin-tazobactam (MIC50/90, 4/128 mg/liter) and meropenem (MIC50/90, 0.5/16 mg/liter) were active against 77.5% and 76.0%, respectively. Susceptibility variations across census divisions were documented for many antimicrobials.
Pharmacology, Toxicology and Pharmaceutical Science
6
10%
Biochemistry, Genetics and Molecular Biology
6
10%
Agricultural and Biological Sciences
3
5%
Other
7
12%
Unknown
21
35%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 July 2022.
All research outputs
#21,623,264
of 34,351,737 outputs
Outputs from Antimicrobial Agents and Chemotherapy
#15,038
of 19,230 outputs
Outputs of similar age
#282,229
of 490,164 outputs
Outputs of similar age from Antimicrobial Agents and Chemotherapy
#80
of 168 outputs
Altmetric has tracked 34,351,737 research outputs across all sources so far. This one is in the 36th percentile – i.e., 36% of other outputs scored the same or lower than it.
So far Altmetric has tracked 19,230 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.0. This one is in the 21st percentile – i.e., 21% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 490,164 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 168 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
